Expert Review of Vaccines (@ExpRevVaccines) header
Expert Review of Vaccines (@ExpRevVaccines) profile picture

MEDLINE-indexed, international journal publishing rigorously peer-reviewed research in the development, application, and clinical effectiveness of new vaccines.

London, England
Joined June 2023
Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)Photo by Expert Review of Vaccines (@ExpRevVaccines)
#ExpertReviewofVaccines is a fully #OpenAccess journal providing expert commentary on the development, application and clinical effectiveness of new #vaccines 👉 Submit here: rp.tandfonline.com/submissio…
2
513
In China, low awareness of the herpes zoster vaccine (HZV) hinders #vaccination uptake among older adults. This study aimed to investigate HZV awareness rates and associated factors among older urban Chinese adults to inform targeted interventions. tandfonline.com/doi/full/10.…
1
43
Public health impact of nirsevimab against acute lower respiratory infections associated with respiratory syncytial #virus among Chinese infants: a modelling study tandfonline.com/doi/full/10.…
25
#Pneumococcal #vaccine update: A single dose of PCV20/PCV21 is recommended for older adults & immunocompromised individuals. • Protection thresholds vary by serotype • Many countries continue using PCV13/15 + PPSV23 due to cost tandfonline.com/doi/figure/1…
2
87
New Phase 3 interim data: LYB001 recombinant protein vaccine shows strong immunogenicity & a favorable safety profile as a heterologous booster after 2–3 doses of inactivated COVID-19 vaccines in adults ≥18 years. #COVID19 #Vaccines #Immunology tandfonline.com/doi/figure/1…
1
2
64
Seasonal flu still causes up to 70,000 deaths/year in the EU, hitting adults ≥65 hardest. High-dose influenza vaccines deliver 4× more antigen and stronger, longer-lasting protection tandfonline.com/doi/figure/1… #Influenza #Vaccination #PublicHealth
20
New article: Incidence of stroke following COVID-19 vaccination: a nationwide self‑controlled risk interval study in Qatar tandfonline.com/doi/full/10.…
16
New study validates the iPro-VC-Be tool for measuring vaccine confidence among healthcare workers in Nigeria 🇳🇬 Findings link trust in vaccines & government directly to uptake. #VaccineConfidence #HCWs #PublicHealth tandfonline.com/doi/figure/1…
1
2
33
Children in Brazil are still receiving COVID-19 vaccines based on the original virus strain—but new variants like Omicron JN.1 escape much of this protection. tandfonline.com/doi/full/10.… #COVIDVaccines #ChildHealth #SARSCoV2
39
🧬 Are live-attenuated vaccines (LAVs) safe for immunocompromised patients and pregnant women? A new systematic literature review provides the most comprehensive look to date. tandfonline.com/doi/full/10.… #Vaccines #Immunocompromised #Pregnancy #LAV #Immunization #VaccineSafety
34
A 2021–2025 cohort study from a General Hospital in Southern Italy evaluates the safety and medium- to long-term protection of ecombinant Zoster Vaccine (#RZV) in high-risk patients. #RZV #Shingles #Vaccines #PublicHealth tandfonline.com/doi/full/10.…
1
41
📊 New insights on COVID-19 vaccination & healthcare use among adults. A study using 2022–2023 respiratory season data examines how #COVID19 vaccination influences all-cause healthcare resource utilisation in adults living with #LongCovid in UK. tandfonline.com/doi/full/10.…
32
A study combining the COM-B model with discrete choice experiments (DCEs) sheds light on how parents decide about adolescent HPV vaccination. #HPV #Vaccination #PublicHealth #HealthPolicy #China #BehavioralScience #COMB #DCE tandfonline.com/doi/full/10.…
42
💉 New research from South Africa shows a single-dose primary series (1+1) for PCV10 & PCV13 is largely as effective as the standard 2+1 schedule in children at 18 months. #Vaccines #Pneumococcal #Immunization tandfonline.com/doi/figure/1…
36
🌍 58M people live with chronic #HepatitisC, at risk of cirrhosis & liver cancer. New research highlights the role of broadly neutralizing antibodies targeting #HCV E2 glycoprotein and explores innovative #vaccine strategies to overcome genetic diversity. tandfonline.com/doi/full/10.…
1
1
33
New approach in #EV71 vaccine development! Using reverse cumulative distribution curves (RCDC) researchers identified the optimal dose (640 U + adjuvant) with 93% estimated protection in infants & young children. tandfonline.com/doi/full/10.… #VaccineResearch #Immunology
1
39
Readiness assessment for cervical cancer elimination and prevention of #human #papillomavirus (HPV)-related cancers in Europe – are we winning the RACE? tandfonline.com/doi/full/10.…
1
195
A new modelling study across a cohort of 25.3M older adults from Germany shows that the bivalent RSVpreF #vaccine could prevent: • 117,360 hospitalised RSV-LRTI cases .100,433 ambulatory cases • 9,298 #RSV-related deaths tandfonline.com/doi/full/10.…
1
2
54